Literature DB >> 18586443

Distribution and prevalence of reflux in the superficial and deep venous system in the general population--results from the Bonn Vein Study, Germany.

Uldis Maurins1, Barbara H Hoffmann, Christian Lösch, Karl-Heinz Jöckel, Eberhard Rabe, Felicitas Pannier.   

Abstract

OBJECTIVE: Venous diseases are among the most frequent diseases in the general population of industrialized countries. The aim of this article is to investigate the population-based prevalence of pathologic reflux in superficial and deep leg veins, taking into account factors as gender, age, and clinical classification of venous disease.
METHODS: In a population-based cross-sectional study, 3072 subjects aged 18 to 79 years (1350 male, 1722 female, response 59%) were enrolled from October 2000 through November 2001. A standardized interview was conducted to document phlebological history and clinical examinations including duplex sonography of selected superficial and deep leg veins. Pathological reflux was defined as being >500 ms. All participants where classified according to the CEAP classification.
RESULTS: Using the highest clinical stage per participant, 9.6% where classified C0, 59.0% C1, 14.3% C2, 13.5% C3, 2.9% C4, and 0.7% C5-C6. A pathological reflux (>500 ms) was found in 35.3% (95% confidence interval [CI] 33.6-37.1) of subjects with 21.0% (95% CI 19.5-22.5) showing reflux in at least one superficial vein and 20.0% (95% CI 18.6-21.5) showing reflux in at least one deep vein. We observed significantly higher reflux prevalence for the superficial veins in women while for the deep veins reflux prevalence were significantly higher in men. Prevalence of reflux in the superficial veins markedly increases with age. In the deep venous system, no clear changes in reflux prevalence with age can be observed. For superficial veins, reflux prevalence is markedly higher with higher C-stages. For the deep veins, the proportion of refluxes is relatively constant in stages C0-C3 with a distinct increase of prevalence from stage C4 onward.
CONCLUSION: Our results show a high prevalence of reflux both for the superficial and the deep venous system. Reflux prevalence is associated with gender, age, and the clinical stage as measured by the CEAP classification. Further longitudinal studies are needed to clarify the relevance of pathological reflux in subjects with otherwise healthy veins.

Entities:  

Mesh:

Year:  2008        PMID: 18586443     DOI: 10.1016/j.jvs.2008.04.029

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  20 in total

1.  HFE p.C282Y gene variant is associated with varicose veins in Russian population.

Authors:  Ekaterina A Sokolova; Alexandra S Shadrina; Kseniya S Sevost'ianova; Andrey I Shevela; Evgenii Yu Soldatsky; Evgenii I Seliverstov; Marina Yu Demekhova; Oleg A Shonov; Evgenii A Ilyukhin; Mariya A Smetanina; Elena N Voronina; Igor A Zolotukhin; Maxim L Filipenko
Journal:  Clin Exp Med       Date:  2015-09-28       Impact factor: 3.984

2.  Socio-economic impact of endovenous thermal ablation techniques.

Authors:  Damian Kelleher; Tristan R A Lane; Ian J Franklin; Alun H Davies
Journal:  Lasers Med Sci       Date:  2013-10-05       Impact factor: 3.161

3.  Endovenous ablation for the treatment of chronic venous insufficiency and venous ulcerations.

Authors:  Christopher J Marrocco; Marvin D Atkins; W Todd Bohannon; Thomas R Warren; Clifford J Buckley; Ruth L Bush
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

4.  In prospective study using Specific Quality of Life & Outcomes Response-Venous (SQOR-V) questionnaire the recall bias had the same magnitude as the minimally important difference.

Authors:  Fedor Lurie; Robert L Kistner
Journal:  Qual Life Res       Date:  2011-04-13       Impact factor: 4.147

5.  Treatment Patterns and Outcomes in Patients with Varicose Veins.

Authors:  Rajiv Mallick; Aditya Raju; Chelsey Campbell; Rashad Carlton; David Wright; Kimberly Boswell; Michael Eaddy
Journal:  Am Health Drug Benefits       Date:  2016-11

6.  Pilot Trial of Neuromuscular Stimulation in Human Subjects with Chronic Venous Disease.

Authors:  Katherine J Williams; Hayley M Moore; Mary Ellis; Alun H Davies
Journal:  Vasc Health Risk Manag       Date:  2021-12-01

7.  Mutations in EPHB4 cause human venous valve aplasia.

Authors:  Oliver Lyons; James Walker; Christopher Seet; Mohammed Ikram; Adam Kuchta; Andrew Arnold; Magda Hernández-Vásquez; Maike Frye; Gema Vizcay-Barrena; Roland A Fleck; Ashish S Patel; Soundrie Padayachee; Peter Mortimer; Steve Jeffery; Siren Berland; Sahar Mansour; Pia Ostergaard; Taija Makinen; Bijan Modarai; Prakash Saha; Alberto Smith
Journal:  JCI Insight       Date:  2021-09-22

8.  Clinical outcomes after varicose vein procedures in octogenarians within the Vascular Quality Initiative Varicose Vein Registry.

Authors:  Danielle C Sutzko; Andrea T Obi; Andrew S Kimball; Margaret E Smith; Thomas W Wakefield; Nicholas H Osborne
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2018-05-08

9.  Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease.

Authors:  Shyue-Luen Chang; Yau-Li Huang; Mei-Ching Lee; Sindy Hu; Yen-Chang Hsiao; Su-Wei Chang; Chee Jen Chang; Pei-Chun Chen
Journal:  JAMA       Date:  2018-02-27       Impact factor: 56.272

10.  Mechanochemical endovenous Ablation versus RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA): study protocol for a randomized controlled trial.

Authors:  Ramon R J P van Eekeren; Doeke Boersma; Suzanne Holewijn; Anco Vahl; Jean Paul p m de Vries; Clark J Zeebregts; Michel M P J Reijnen
Journal:  Trials       Date:  2014-04-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.